Simon Deacon discusses Injectaclad momentum and the wider LSTH strategy
Light Science Technologies Holdings PLC CEO Simon Deacon recently spoke with Proactive about the Group’s latest progress, including the acquisition of Injectaclad and its first major order since joining the Group.
The interview covers the newly secured £410k order, the scale of the UK remediation market, and how Injectaclad is positioned to support safer buildings through a lower-disruption cavity barrier solution.
Simon also discusses the wider Group strategy, including continued growth across AgTech, Contract Electronics Manufacturing, and Passive Fire Protection.
Watch Simon Deacon’s full interview with Proactive
Watch the Interview
